Figure 1

Application of ICG with near-infrared fluorescence imaging system for dissecting intra-abdominal adhesions. Prior to abdominal surgery, ICG is administered via peripheral vein injection. Intraoperatively, the near-infrared fluorescence imaging system is utilized to visualize tissues, enabling the release of intraoperative adhesions under real-time fluorescence guidance. Note: Following peripheral intravenous injection of a specific dose of ICG, due to the pharmacokinetic characteristics of ICG, it undergoes hepatic metabolism, is excreted into the gastrointestinal tract via the bile duct, and does not participate in enterohepatic circulation. Additionally, after binding to proteins, ICG, when excited by near-infrared light, emits light at a longer wavelength, approximately 830 nm.